As the current opioid addiction/overdose epidemic spread out across America over the last 20 years, it wasn’t just greedy drugstore chains that turned a blind eye to fake and questionable prescriptions. A new report highlights how the company behind one of the epidemic’s signature drugs ignored warning signs of obvious illegal activity. [More]
When OxyContin hit pharmacies 20 years ago, its primary selling point was that a single dose of the opioid pain medication lasted 12 hours, “providing smooth and sustained pain control all day and all night,” per the press release. But a new report claims Purdue Pharma, the makers of OxyContin, have long known that the drug doesn’t always live up to this promise, resulting in an increased likelihood for abuse and addiction. [More]
The company that makes OxyContin has a good thing going, with lots of free PR from shows like Intervention and Justified and no exact generic equivalent to undercut its market share. But there are dark clouds on the horizon for the OxyContin brand, as its patent is set to expire in April. Now, in a ploy to extend that patent, the Oxy folks are going through the motions of pretending they actually care whether or not children can take the drug safely.